Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

By sjmartinez • August 8, 2024

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024 Aug 7:1-4. doi: 10.1080/17435889.2024.2380241. Epub ahead of print. PMID: 39109486.

Tags: Alzheimer's and tumor, BBB, blood brain barrier (BBB), Blood-brain-barrier, Cedars Sinai DoM, cell-specific drug delivery, central nervous system, CNS immunity, diabetic retinopathy, Endocrinology, multifunctional nanoparticles, normal, peptides, Publications

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]

Correction to: Consensus and Controversies about Diagnosing GH deficiency – A Delphi Survey by the GH Research Society

Radovick S, Arlien-Søborg MC, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev[...]

Quantifying and Visualizing Emergency Physician Workflow: Observational Time-Motion Study

Henreid AJ, Ioannides KLH, Pevnick JM, Cohen TN, Torbati SS, Nuckols TK, Berdahl CT. Quantifying and Visualizing Emergency Physician Workflow: Observational Time-Motion Study. JMIR Med[...]